Chemomab Therapeutics (NASDAQ:CMMB) Raised to Buy at Zacks Investment Research etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which unveil their equity positions as of September.
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which unveil their equity positions as of September.
In recent trading session, Chemomab Therapeutics Ltd. (NASDAQ:CMMB) saw 0.78 million shares changing hands at last check today with its beta currently measuring 0. Company’s recent per share price level of $8.99 trading at $0.56 or 6.64% at last check today assigns it a market valuation of $94.67M